Form 4 for TMDX TransMedics Group, Inc.
Accepted 2024-01-03 00:00:00 ET · period of report 2024-01-02 · accession 0000950170-24-001054 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-01-03 | 2024-01-02 | TMDX | Gordon Stephen | CFO | S - Sale+OE | $77.07 | -15.0K | 13.1K | -53% | -$1.16M |
| DT | 2024-01-03 | 2024-01-02 | TMDX | Gordon Stephen | CFO | M - OptEx | $13.28 | +15.0K | 28.1K | +115% | +$199.2K |
| DT | 2024-01-03 | 2024-01-02 | TMDX | Gordon Stephen | CFO | M - OptEx | $0.00 | -15.0K | 37.0K | -29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-02 | S | D | 15,000 | $77.07 | 13,075 | D | — | — | (F2) Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Common | Common Stock | 2024-01-02 | M | A | 15,000 | $13.28 | 28,075 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-01-02 | M | D | 15,000 | $0.00 | 37,000 | D | $13.28 · — to 2032-02-22 | 15,000 Common Stock | (F3) The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026. |